1. Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas
- Author
-
Juri Ikemoto, Ryota Kawamura, Shinya Nakamura, Keiji Hanada, Masahiro Serikawa, Tsuyoshi Sekitou, Keisuke Kurihara, Tetsuro Hirano, Tomofumi Tsuboi, Takeshi Mori, Kazuaki Chayama, and Yasutaka Ishii
- Subjects
Male ,Vascular Endothelial Growth Factor A ,Pathology ,Endocrinology, Diabetes and Metabolism ,pancreatic duct cancer ,FDG-Positron Emission Tomography ,0302 clinical medicine ,Endocrinology ,SUVmax - maximal standardized uptake volume ,pancreas ,Child ,FDG-PET ,PNEN - pancreatic neuroendocrine neoplasm ,Glucose Transporter Type 1 ,JPS - Japan Pancreas Society ,medicine.diagnostic_test ,Middle Aged ,solid pseudopapillary neoplasm ,VEGF - vascular endothelial growth factor ,medicine.anatomical_structure ,Positron emission tomography ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,Hypoxia-Inducible Factor 1 ,Pancreas ,medicine.drug ,Adult ,tumor ,medicine.medical_specialty ,Adolescent ,CT - contrast computed tomography ,PDC - pancreatic duct cancer ,SPN - solid pseudopapillary neoplasm ,Young Adult ,GLUT1 - glucose transporter protein type 1 ,03 medical and health sciences ,Fluorodeoxyglucose F18 ,Internal Medicine ,medicine ,Carcinoma ,Humans ,Aged ,Pancreatic duct ,Fluorodeoxyglucose ,Hepatology ,business.industry ,Cancer ,Original Articles ,FDG-PET - fluorodeoxyglucose positron emission tomography ,medicine.disease ,Carcinoma, Papillary ,HIF - hypoxia-inducible factor ,Pancreatic Neoplasms ,Pancreatic Neuroendocrine Neoplasm ,Positron-Emission Tomography ,Radiopharmaceuticals ,pancreatic neuroendocrine neoplasm ,business - Abstract
Objectives This study aimed to investigate the utility of fluorodeoxyglucose (FDG) positron emission tomography for solid pseudopapillary neoplasm (SPN) diagnosis. Methods The subjects included 53 cases of SPN. We compared the maximal standardized uptake volume (SUVmax) with those of 25 cases of pancreatic duct cancer and 18 cases of pancreatic neuroendocrine neoplasm. In addition, immunopathological testing for SPN with regard to FDG uptake was undertaken. Results An increase in SUVmax was observed in all tumors with increased tumor diameter. Among tumors of 20 mm or smaller, the SUVmax of SPN was significantly higher than those of pancreatic duct cancer and pancreatic neuroendocrine neoplasm. The results of a pathological study of FDG uptake in SPN revealed increased glucose transporter protein type 1 expression with tumor enlargement. Furthermore, increased hypoxia-inducible factor-1 and vascular endothelial growth factor expression under hypoxic conditions were observed in the areas of necrosis. Conclusions In cases in which high FDG uptake is observed in small pancreatic tumors, FDG positron emission tomography is potentially useful for SPN differentiation. The factors involved in FDG uptake in SPN include cell density and glucose transporter protein expression, as well as hypoxia-inducible factor and vascular endothelia growth factor expression in the hypoxic environment of necrotic areas.
- Published
- 2019
- Full Text
- View/download PDF